The Effect of Different Glucose Concentrations on the Antiproliferative Activity of Metformin in MCF-7 Breast Cancer Cells

The glucose-lowering drug metformin has been reported to have anticancer properties through unknown mechanisms. Other unknown factors that may influence its anticancer potential include the glycemic status of the patient. Therefore, the objective of this study is to determine the effect of different...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurzhan, Sholpan, Bekezhankyzy, Zhibek, Ding, Hong, Berdigaliyev, Nurken, Sergazy, Shynggys, Gulyayev, Alexander, Shulgau, Zarina, Triggle, Christopher R., Aljofan, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537756/
https://www.ncbi.nlm.nih.gov/pubmed/37765157
http://dx.doi.org/10.3390/pharmaceutics15092186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537756/
https://www.ncbi.nlm.nih.gov/pubmed/37765157
http://dx.doi.org/10.3390/pharmaceutics15092186

Ejemplares similares